Oxford University Press

SHERPA: Yellow

People

  1. Hudis
    Hudis
  2. Norton
    Norton
  3. Robson
    Robson
  4. Modi
    Modi
  5. Seidman
    Seidman
  6. Jhaveri
    Jhaveri
  7. Dang
    Dang
  8. Traina
    Traina
  9. Offit
    Offit
  10. Chandarlapaty
    Chandarlapaty

Groups

  1. Breast Medicine Service (228)
  2. Department of Medicine (228)
  3. Solid Tumor Oncology Division (228)
  4. Survivorship Research (114)
  5. GSK Faculty (69)
  6. Alan and Sandra Gerry Metastasis and Tumor Ecosystems Center (67)
  7. Population Sciences Research Program (58)
  8. Human Oncology and Pathogenesis Program (41)
  9. Epidemiology and Biostatistics (35)
  10. Biostatistics Service (25)
Search Within
  1. "Breast Medicine Service"
Formats
  1. Journal Article (117)
  2. Meeting Abstract (98)
  3. Review (6)
  4. Correspondence (2)
  5. Editorial (2)
  6. Guidelines (2)
  7. Conference Paper (1)
Groups
  1. Breast Medicine Service (228)
  2. Department of Medicine (228)
  3. Solid Tumor Oncology Division (228)
  4. Survivorship Research (114)
  5. GSK Faculty (69)
  6. Alan and Sandra Gerry Metastasis and Tumor Ecosystems Center (67)

More Groups

People
  1. Clifford Hudis (43)
  2. Larry Norton (43)
  3. Mark Robson (37)
  4. Shanu Modi (27)
  5. Andrew Seidman (24)
  6. Jorge Reis-Filho (21)

More People

Years
  1. 2024 (2)
  2. 2023 (23)
  3. 2022 (15)
  4. 2021 (22)
  5. 2020 (25)
  6. 2019 (22)

More Years

Publications
  1. Annals of Oncology (140)
  2. JNCI: Journal of the National Cancer Institute (48)
  3. Neuro-Oncology (17)
  4. JNCI Cancer Spectrum (7)
  5. Journal of the National Cancer Institute - Monographs (4)
  6. European Heart Journal (3)

More Publications

Results (228)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Trastuzumab deruxtecan in patients with human epidermal growth factor receptor 2–expressing salivary gland carcinoma: A pooled analysis of two phase I studies
    Journal Article

    Takahashi, S.; Bando, H.; Kinoshita, I.; Modi, S.; Tsurutani, J.; Bang, Y. J.; Sato, Y.; Nakatani, S.; Lee, C.; Sugihara, M.; more...
    Japanese Journal of Clinical Oncology (2024)

    Fulltext@MSK | Save
  • Trastuzumab deruxtecan in previously treated patients with HER2-positive metastatic breast cancer: Updated survival results from a phase II trial (DESTINY-Breast01)
    Journal Article

    Saura, C.; Modi, S.; Krop, I.; Park, Y. H.; Kim, S. B.; Tamura, K.; Iwata, H.; Tsurutani, J.; Sohn, J.; Mathias, E.; more...
    Annals of Oncology (2024)

    Fulltext@MSK | Save
  • Timing of exercise therapy when initiating adjuvant chemotherapy for breast cancer: A randomized trial
    Journal Article

    Scott, J. M.; Lee, J.; Herndon, J. E.; Michalski, M. G.; Lee, C. P.; O'Brien, K. A.; Sasso, J. P.; Yu, A. F.; Rowed, K. A.; Bromberg, J. F.; more...
    European Heart Journal (2023)

    Fulltext@MSK | Save
  • Public tumor-wide neoantigens derived from clonal aberrant splicing events drive tumor-specific T-cell responses
    Meeting Abstract

    Kwok, D.; Stevers, N.; Nejo, T.; Jung, J.; Chen, L.; Lakshmanachetty, S.; Etxeberria, I.; Gallus, M.; Yamamichi, A.; Ramos, E.; more...
    Neuro-Oncology (2023)

    Fulltext@MSK | Save
  • T-DXd vs TPC in patients with HER2-low unresectable and/or metastatic BC in Asian subgroup: Results of DESTINY-Breast04
    Meeting Abstract

    Tsurutani, J.; Modi, S.; Sohn, J. H.; Tokunaga, E.; Niikura, N.; Park, Y. H.; Lee, K. S.; Chae, Y. S.; Wang, X.; Li, W.; more...
    Annals of Oncology (2023)

    Fulltext@MSK | Save
  • Novel therapeutic opportunities in metaplastic breast cancer
    Meeting Abstract

    Pareja, F.; Gazzo, A.; Dopeso, H.; Brown, D.; Selenica, P.; Zhu, Y.; Blanco Heredia, J.; Gusain, L.; Pei, X.; Marra, A.; more...
    Annals of Oncology (2023)

    Fulltext@MSK | Save
  • Datopotamab deruxtecan (Dato-DXd) vs chemotherapy in previously-treated inoperable or metastatic hormone receptor-positive, HER2-negative (HR+/HER2-) breast cancer (BC): Primary results from the randomised phase III TROPION-Breast01 trial
    Meeting Abstract

    Bardia, A.; Jhaveri, K.; Im, S. A.; Pernas Simon, S.; De Laurentiis, M.; Wang, S.; Martinez, N.; Santos Borges, G.; Cescon, D. W.; Hattori, M.; more...
    Annals of Oncology (2023)

    Fulltext@MSK | Save
  • APOBEC mutagenesis and macrophage infiltration in cancer
    Meeting Abstract

    Gazzo, A.; Marra, A.; Zhu, Y.; Gupta, A.; Selenica, P.; Pei, X.; Weigelt, B.; Pareja, F.; Riaz, N.; Reis, J. S.; more...
    Annals of Oncology (2023)

    Fulltext@MSK | Save
  • Pan-cancer assessment of the impact of intronic variants on cancer development and progression
    Meeting Abstract

    Safonov, A.; Mehine, M.; Ceyhan-Birsoy, O.; Brown, D.; Bandlamudi, C.; Forbes, A.; Gazzo, A.; Selenica, P.; Shen, R.; Khurana, E.; more...
    Annals of Oncology (2023)

    Fulltext@MSK | Save
  • Remote symptom monitoring with electronic patient-reported outcomes (ePROs) during treatment for metastatic cancer: Results from the PRO-TECT trial (Alliance AFT-39)
    Meeting Abstract

    Basch, E.; Schrag, D.; Jansen, J.; Ginos, B.; Spears, P. A.; Jonsson, M.; Carr, P.; Deal, A. M.; Thanarajasingam, G.; Reeve, B. B.; more...
    Annals of Oncology (2023)

    Fulltext@MSK | Save